Automated Breast Ultrasound System Market to Hit US$ 4.3 Billion by 2033: Fact.MR Report

The need for supplementary screening tools for women with dense breast tissue is a major driver shaping the market


Rockville , Nov. 06, 2023 (GLOBE NEWSWIRE) -- As per Fact.MR, a provider of market research and competitive intelligence, the global automated breast ultrasound system market is expected to rise at a CAGR of 9.7% to reach a value of US $4.3 Bn by the end of 2033.

Automated Breast Ultrasound Systems (ABUS) are advanced breast imaging machines that use sound waves to create detailed pictures of breast tissue. They are beneficial for women with dense breasts, where traditional mammograms may be less effective. ABUS is safe, as it doesn't use radiation, making it a good option for repeat screenings. It works alongside mammography, providing a more thorough screening process. ABUS can generate 3D images, giving a more detailed view of the breast. It's also less uncomfortable for patients compared to some other methods.

Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=585

The growth of the automated breast ultrasound system market is primarily driven by the increasing awareness of breast density and its impact on mammography accuracy. As regulatory mandates in various regions necessitate informing women about their breast density, there is a rising demand for supplementary screening tools like automated breast ultrasound systems.

ABUS systems, which help detect breast cancer early, can be expensive for smaller healthcare facilities. This financial hurdle can limit access, especially for clinics with tight budgets or in areas with limited resources. Using automated breast ultrasound systems (ABUS) can be tricky for some healthcare professionals. They need proper training to operate and interpret the results accurately.

Report AttributeDetails
Value Projection (2033)US$ 4.3 Billion
Growth Rate (2023-2033)9.7% CAGR
No. of pages170 Pages
No. of Tables37 Tables
No. of Figures33 Figures

Key Takeaways:

  • The market share of Automated Breast Ultrasound scanners is expected to be around 50%.
  • The North American market accounts for around 50% share of the global market due to the presence of numerous major competitors and the high prevalence of breast cancer.
  • Germany is expected to be a profitable market for automated breast ultrasound system suppliers due to rapid urbanization, an established healthcare infrastructure, and the rise in need for advanced non-invasive breast imaging techniques.

Increasing demand for improved breast cancer screening, advancements in ultrasound technology, and rising awareness of the importance of early diagnosis and treatment are a few factors that are driving the industry - Says FACTMR Expert

Key Companies Profiled in This Report

  • GE Healthcare
  • SuperSonic Imagine SA
  • Volpara Solutions Limited
  • CapeRay Medical
  • MetriTrack Inc.
  • SonoCiné Inc.
  • Delphinus Medical Technologies Inc.
  • Siemens AG
  • Hitachi Ltd.

Market Competition

Prominent industry leaders are prioritizing implementing automated breast ultrasound systems in medical facilities and diagnostic centers, adhering to safety protocols to minimize environmental impact and expand their international footprint.

  • Siemens Healthineers AG introduced the ACUSON S2000 ABVS in its imaging and diagnostics division. This advanced automated breast ultrasound system is equipped with 3D imaging capabilities, enabling the detection of abnormalities in both fatty and dense breast tissue.

Winning strategies

  • Major players in the market are putting their focus and resources into developing technologies that make ultrasound imaging more accurate and sensitive, especially for patients with dense breast tissue. This targeted approach is a smart move because it addresses the specific challenges of breast imaging.
  • A crucial strategy involves harnessing the power of artificial intelligence (AI) algorithms for automated image analysis and interpretation. This approach holds immense significance because it allows for faster and more precise identification of potentially concerning areas or lesions within breast images.
  • Conducting clinical trials for automated breast ultrasound systems is crucial. These trials provide solid evidence of how well these systems work in real-world situations, in different patient groups and clinical settings.

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=585

Country-wise Insights

What is the United States market outlook for automated breast ultrasound systems?

"Increasing Need for Cutting-Edge Breast Imaging Systems"

The market is expected to rise in the US due to rising government initiatives educating women about breast cancer, increased demand for cutting-edge breast imaging technology, and an increased need for screenings as a result of increased cancer awareness.

Explore More Related Studies Published by Fact.MR Research: 

Ultrasound Systems Market: The global market is projected to grow from US$ 8.39 Billion in 2022 to US$ 17.29 Billion by 2032, growing at a compound annual growth rate (CAGR) of 7.5% during the forecast period from 2022 to 2032.

Endoscopy Ultrasound Market: The global endoscopy ultrasound market was worth around US$ 997 Million in 2022 and is expected to grow at a CAGR of 5.7% during the forecast period, reaching a value of nearly US$ 1.85 Billion in 2032.

Ophthalmic Ultrasound Devices Market: Value of Ophthalmic Ultrasound Devices Market are projected to increase at a CAGR of around 9.0% during 2022 – 2032.

About Fact.MR:

Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.

Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232 (D)
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog